2018-2023 Global Circulating Tumor Cells Market Report (Status and Outlook)

Publisher Name :
Date: 10-Aug-2018
No. of pages: 130

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Circulating Tumor Cells market for 2018-2023.

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.

Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.

FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.

Over the next five years, LPI(LP Information) projects that Circulating Tumor Cells will register a 14.5% CAGR in terms of revenue, reach US$ 2740 million by 2023, from US$ 1220 million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- CTC Enrichment

- CTC Detection

Segmentation by application:

- Breast Cancer

- Prostate Cancer

- Colorectal Cancer

- Other

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Menarini-Silicon Biosystems

- Qiagen(Adnagen)

- Clearbridge Biomedics

- Celsee

- Fluidigm

- ApoCell

- Greiner Bio-one GmbH

- Advanced Cell Diagnostics

- Aviva Biosciences

- Fluxion Biosciences

- Sysmex Corporation

- Epic Sciences

- Cynvenio

- CytoTrack

- Ikonisys

- Vortex BioSciences

- Gilupi

- Biocept

- ScreenCell

- ANGLE

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Circulating Tumor Cells market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Circulating Tumor Cells market by identifying its various subsegments.

- Focuses on the key global Circulating Tumor Cells players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Circulating Tumor Cells with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Circulating Tumor Cells submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Circulating Tumor Cells Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Circulating Tumor Cells Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells Market Size 2013-2023
2.1.2 Circulating Tumor Cells Market Size CAGR by Region
2.2 Circulating Tumor Cells Segment by Type
2.2.1 CTC Enrichment
2.2.2 CTC Detection
2.2.3 CTC Analysis
2.3 Circulating Tumor Cells Market Size by Type
2.3.1 Global Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
2.3.2 Global Circulating Tumor Cells Market Size Growth Rate by Type (2013-2018)
2.4 Circulating Tumor Cells Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Other
2.5 Circulating Tumor Cells Market Size by Application
2.5.1 Global Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
2.5.2 Global Circulating Tumor Cells Market Size Growth Rate by Application (2013-2018)

3 Global Circulating Tumor Cells by Players
3.1 Global Circulating Tumor Cells Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells Market Size by Players (2016-2018)
3.1.2 Global Circulating Tumor Cells Market Size Market Share by Players (2016-2018)
3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Circulating Tumor Cells by Regions
4.1 Circulating Tumor Cells Market Size by Regions
4.2 Americas Circulating Tumor Cells Market Size Growth
4.3 APAC Circulating Tumor Cells Market Size Growth
4.4 Europe Circulating Tumor Cells Market Size Growth
4.5 Middle East & Africa Circulating Tumor Cells Market Size Growth

5 Americas
5.1 Americas Circulating Tumor Cells Market Size by Countries
5.2 Americas Circulating Tumor Cells Market Size by Type
5.3 Americas Circulating Tumor Cells Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Circulating Tumor Cells Market Size by Countries
6.2 APAC Circulating Tumor Cells Market Size by Type
6.3 APAC Circulating Tumor Cells Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Circulating Tumor Cells by Countries
7.2 Europe Circulating Tumor Cells Market Size by Type
7.3 Europe Circulating Tumor Cells Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells by Countries
8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type
8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Circulating Tumor Cells Market Forecast
10.1 Global Circulating Tumor Cells Market Size Forecast (2018-2023)
10.2 Global Circulating Tumor Cells Forecast by Regions
10.2.1 Global Circulating Tumor Cells Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Circulating Tumor Cells Forecast by Type
10.8 Global Circulating Tumor Cells Forecast by Application

11 Key Players Analysis
11.1 Menarini-Silicon Biosystems
11.1.1 Company Details
11.1.2 Circulating Tumor Cells Product Offered
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Menarini-Silicon Biosystems News
11.2 Qiagen(Adnagen)
11.2.1 Company Details
11.2.2 Circulating Tumor Cells Product Offered
11.2.3 Qiagen(Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Qiagen(Adnagen) News
11.3 Clearbridge Biomedics
11.3.1 Company Details
11.3.2 Circulating Tumor Cells Product Offered
11.3.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Clearbridge Biomedics News
11.4 Celsee
11.4.1 Company Details
11.4.2 Circulating Tumor Cells Product Offered
11.4.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Celsee News
11.5 Fluidigm
11.5.1 Company Details
11.5.2 Circulating Tumor Cells Product Offered
11.5.3 Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Fluidigm News
11.6 ApoCell
11.6.1 Company Details
11.6.2 Circulating Tumor Cells Product Offered
11.6.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 ApoCell News
11.7 Greiner Bio-one GmbH
11.7.1 Company Details
11.7.2 Circulating Tumor Cells Product Offered
11.7.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Greiner Bio-one GmbH News
11.8 Advanced Cell Diagnostics
11.8.1 Company Details
11.8.2 Circulating Tumor Cells Product Offered
11.8.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Advanced Cell Diagnostics News
11.9 Aviva Biosciences
11.9.1 Company Details
11.9.2 Circulating Tumor Cells Product Offered
11.9.3 Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Aviva Biosciences News
11.10 Fluxion Biosciences
11.10.1 Company Details
11.10.2 Circulating Tumor Cells Product Offered
11.10.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Fluxion Biosciences News
11.11 Sysmex Corporation
11.12 Epic Sciences
11.13 Cynvenio
11.14 CytoTrack
11.15 Ikonisys
11.16 Vortex BioSciences
11.17 Gilupi
11.18 Biocept
11.19 ScreenCell
11.20 ANGLE

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Circulating Tumor Cells
Figure Circulating Tumor Cells Report Years Considered
Figure Market Research Methodology
Figure Global Circulating Tumor Cells Market Size Growth Rate 2013-2023 ($ Millions)
Table Circulating Tumor Cells Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of CTC Enrichment
Table Major Players of CTC Detection
Table Major Players of CTC Analysis
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure Global Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure Global CTC Enrichment Market Size Growth Rate
Figure Global CTC Detection Market Size Growth Rate
Figure Global CTC Analysis Market Size Growth Rate
Figure Circulating Tumor Cells Consumed in Breast Cancer
Figure Global Circulating Tumor Cells Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Prostate Cancer
Figure Global Circulating Tumor Cells Market: Prostate Cancer (2013-2018) ($ Millions)
Figure Global Prostate Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Colorectal Cancer
Figure Global Circulating Tumor Cells Market: Colorectal Cancer (2013-2018) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Other
Figure Global Circulating Tumor Cells Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Circulating Tumor Cells Market Size by Application (2013-2018) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Market Size in Breast Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Prostate Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Colorectal Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Other Growth Rate
Table Global Circulating Tumor Cells Revenue by Players (2016-2018) ($ Millions)
Table Global Circulating Tumor Cells Revenue Market Share by Players (2016-2018)
Figure Global Circulating Tumor Cells Revenue Market Share by Players in 2017
Table Global Circulating Tumor Cells Key Players Head office and Products Offered
Table Circulating Tumor Cells Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Circulating Tumor Cells Market Size by Regions 2013-2018 ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Regions 2013-2018
Figure Global Circulating Tumor Cells Market Size Market Share by Regions 2013-2018
Figure Americas Circulating Tumor Cells Market Size 2013-2018 ($ Millions)
Figure APAC Circulating Tumor Cells Market Size 2013-2018 ($ Millions)
Figure Europe Circulating Tumor Cells Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells Market Size 2013-2018 ($ Millions)
Table Americas Circulating Tumor Cells Market Size by Countries (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Countries (2013-2018)
Figure Americas Circulating Tumor Cells Market Size Market Share by Countries in 2017
Table Americas Circulating Tumor Cells Market Size by Type (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure Americas Circulating Tumor Cells Market Size Market Share by Type in 2017
Table Americas Circulating Tumor Cells Market Size by Application (2013-2018) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure Americas Circulating Tumor Cells Market Size Market Share by Application in 2017
Figure United States Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Canada Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Table APAC Circulating Tumor Cells Market Size by Countries (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Countries (2013-2018)
Figure APAC Circulating Tumor Cells Market Size Market Share by Countries in 2017
Table APAC Circulating Tumor Cells Market Size by Type (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure APAC Circulating Tumor Cells Market Size Market Share by Type in 2017
Table APAC Circulating Tumor Cells Market Size by Application (2013-2018) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure APAC Circulating Tumor Cells Market Size Market Share by Application in 2017
Figure China Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Japan Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Korea Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure India Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Australia Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Table Europe Circulating Tumor Cells Market Size by Countries (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Countries (2013-2018)
Figure Europe Circulating Tumor Cells Market Size Market Share by Countries in 2017
Table Europe Circulating Tumor Cells Market Size by Type (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure Europe Circulating Tumor Cells Market Size Market Share by Type in 2017
Table Europe Circulating Tumor Cells Market Size by Application (2013-2018) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure Europe Circulating Tumor Cells Market Size Market Share by Application in 2017
Figure Germany Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure France Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure UK Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Italy Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Russia Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Spain Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Countries in 2017
Table Middle East & Africa Circulating Tumor Cells Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type in 2017
Table Middle East & Africa Circulating Tumor Cells Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application in 2017
Figure Egypt Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Israel Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Circulating Tumor Cells Market Size Growth 2013-2018 ($ Millions)
Figure Global Circulating Tumor Cells arket Size Forecast (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Regions
Figure Americas Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure APAC Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Europe Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure United States Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Canada Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Mexico Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Brazil Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure China Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Japan Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Korea Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure India Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Australia Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Germany Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure France Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure UK Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Italy Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Russia Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Spain Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Egypt Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure South Africa Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Israel Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure Turkey Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Figure GCC Countries Circulating Tumor Cells Market Size 2018-2023 ($ Millions)
Table Global Circulating Tumor Cells Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Type (2018-2023)
Table Global Circulating Tumor Cells Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Application (2018-2023)
Table Menarini-Silicon Biosystems Basic Information, Head Office, Major Market Areas and Its Competitors
Table Menarini-Silicon Biosystems Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Menarini-Silicon Biosystems Circulating Tumor Cells Market Share (2016-2018)
Table Qiagen(Adnagen) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qiagen(Adnagen) Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Qiagen(Adnagen) Circulating Tumor Cells Market Share (2016-2018)
Table Clearbridge Biomedics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Clearbridge Biomedics Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Clearbridge Biomedics Circulating Tumor Cells Market Share (2016-2018)
Table Celsee Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celsee Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Celsee Circulating Tumor Cells Market Share (2016-2018)
Table Fluidigm Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fluidigm Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Fluidigm Circulating Tumor Cells Market Share (2016-2018)
Table ApoCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table ApoCell Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure ApoCell Circulating Tumor Cells Market Share (2016-2018)
Table Greiner Bio-one GmbH Basic Information, Head Office, Major Market Areas and Its Competitors
Table Greiner Bio-one GmbH Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Greiner Bio-one GmbH Circulating Tumor Cells Market Share (2016-2018)
Table Advanced Cell Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advanced Cell Diagnostics Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Advanced Cell Diagnostics Circulating Tumor Cells Market Share (2016-2018)
Table Aviva Biosciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Aviva Biosciences Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Aviva Biosciences Circulating Tumor Cells Market Share (2016-2018)
Table Fluxion Biosciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fluxion Biosciences Circulating Tumor Cells Revenue and Gross Margin (2016-2018)
Figure Fluxion Biosciences Circulating Tumor Cells Market Share (2016-2018)
Table Sysmex Corporation Basic Information, Head Office, Major Market Areas and Its Competitors
Table Epic Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cynvenio Basic Information, Head Office, Major Market Areas and Its Competitors
Table CytoTrack Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ikonisys Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vortex BioSciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilupi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocept Basic Information, Head Office, Major Market Areas and Its Competitors
Table ScreenCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table ANGLE Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global and India Circulating Tumor Cells Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 110
    Summary This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). Market Segment as follows: By Type - CTC enrichment - CTC detection - CTC analysis By Application - Prostate Cancer - Breast Cancer - Colorectal Cancer - Others - By Company......
  • Acute Myeloid Leukemia - Market Insights, Epidemiology and Market Forecast - 2027
    Published: 03-Aug-2018        Price: US 6250 Onwards        Pages: 120
    DelveInsight's ‘Acute Myeloid Leukemia - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Acute Myeloid Leukemia in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of ......
  • Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast - 2027
    Published: 03-Aug-2018        Price: US 6250 Onwards        Pages: 120
    DelveInsight's ‘Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pancreatic Cancer in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Pancreatic......
  • Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2025
    Published: 26-Jul-2018        Price: US 3300 Onwards        Pages: 99
    This report studies the global Acute Myeloid Leukemia Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Acute Myeloid Leukemia Therapeutics market by companies, region, type and end-use industry. Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukem......
  • Dendritic Cancer Cell Therapy - Pipeline Insights, 2018
    Published: 25-Jul-2018        Price: US 1500 Onwards        Pages: 160
    "Dendritic Cancer Cell Therapy- Pipeline Insights, 2018" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Dendritic Cancer Cell Therapy. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 25+ products with more than 15+ companies involved. Some ......
  • Oncolytic Virus Cancer Therapy - Pipeline Insights, 2018
    Published: 25-Jul-2018        Price: US 2000 Onwards        Pages: 200
    "Oncolytic Virus Cancer Therapy- Pipeline Insights, 2018" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Oncolytic Virus Cancer Therapy. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 65+ products with more than 25 companies involved. Some......
  • Global Immunotherapy Market Professional Survey Report 2018
    Published: 24-Jul-2018        Price: US 3500 Onwards        Pages: 104
    This report studies the global Immunotherapy market status and forecast, categorizes the global Immunotherapy market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The......
  • Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Published: 24-Jul-2018        Price: US 5500 Onwards        Pages: 273
    Report Scope The key objectives of this study are to: - Review the historical development of CAR T-cell technology. - Discuss the principles of chimeric antigen receptor design. - Understand the mechanisms of action associated with CAR T-cell immunotherapy. - Highlight the ongoing clinical and non-clinical advancements in the field of CAR T-cell therapy. - Access the side effects, disadvantages and limitations of existing CAR T-cell technologies.......
  • Global and Chinese Circulating Tumor Cells Industry, 2018 Market Research Report
    Published: 24-Jul-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Circulating Tumor Cells Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Circulating Tumor Cells industry with a focus on the Chinese market. The report provides key statistics on the market status of the Circulating Tumor Cells manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs